Glenmark Sues GSK To Invalidate Antibiotic-Cream Patents
- Jeff Overley
- IP Law 360
On January 24, 2013, Glenmark Generics Ltd. filed a complaint against GlaxoSmithKline PLC (GSK) in the U.S. District Court for the District of Delaware (Glenmark Generics Ltd. et al. v. GlaxoSmithKline PLC et al.). Glenmark's suit seeks to invalidate two GSK patents that cover Bactroban antibiotic creams (U.S. patent nos. 6,025,389 and 5,569,672). The suit also asks the district court to confirm that Glenmark’s generic Bactroban product does not infringe the two GSK patents.
Sterne, Kessler, Goldstein & Fox P.L.L.C. and Young Conaway Stargatt & Taylor LLP represent Glenmark.
Subscribers can read the full story on IP Law360.